This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

SXC Health Solutions Unveils A New Name Following Merger: Catamaran

Stocks in this article: SXC SXCI

New Stock Ticker Symbol and Leadership Team Announced

LISLE, IL, July 10, 2012 /PRNewswire/ - Following the recent completion of its merger with Catalyst Health Solutions, Inc., SXC Health Solutions Corp. today unveiled a new name and brand for the company, as well as formally announced its leadership team.  The new name, Catamaran, reflects the union of two of the industry's fastest-growing pharmacy benefits management companies (PBM) to create the fourth largest PBM in the U.S. by prescription volume.

Beginning tomorrow, the company's shares will be traded under the ticker CTRX on the NASDAQ and as CCT on the Toronto Stock Exchange.

The company selected the name Catamaran to reflect its nimble, flexible approach to helping clients navigate today's turbulent healthcare environment to contain costs and enhance the well-being of its members.   Catamaran's clients include the broadest, most diverse base of any PBM, comprising large employers, health plans, government entities, unions, workers' compensation, TPAs, long term care, hospice and PBMs.

"Catamaran is the most viable alternative for organizations who are struggling to solve the healthcare cost challenge, and we're eager to put our enhanced resources to work for them," said Mark Thierer, Chairman and CEO of Catamaran. "We have the skill and scale to deliver compelling financial results and the clinical intelligence to deliver sustainable improvements in the health of members."

The new Catamaran has substantial resources to apply to the market's challenges.   The merged company will have estimated annual revenues of $13 billion, placing it among the top 250 companies in the U.S. and among the top 15 companies in the Chicagoland area, where it is headquartered.  Catamaran will serve approximately 25 million members and will have an annual volume of more than 200 million adjusted pharmacy benefits management prescriptions.

Catamaran also formally announced its new leadership team, which leverages talents from both SXC and Catalyst.   Mark Thierer will lead the firm as Chairman and CEO, and Jeff Park will serve as Executive Vice President and CFO.   Former Catalyst President and Chief Operating Officer Rick Bates will serve as Executive Vice President, Market Segments.  In addition, former Catalyst board member Steven B. Epstein will join the new Catamaran board.   David Blair, former Chairman and CEO of Catalyst, has committed to provide ongoing support to the combined company to ensure a seamless and successful integration.

Catamaran is headquartered in Lisle, Illinois, with multiple locations in the United States and Canada.

About Catamar an Catamaran, the industry's fastest-growing pharmacy benefits manager, helps organizations and the communities they serve take control of prescription drug costs.  Managing more than 200 million prescriptions each year on behalf of 25 million members, our flexible, holistic solutions improve patient care and empower individuals to take charge of their health. Processing one in every five prescription claims in the U.S., Catamaran's skill and scale deliver compelling financial results and sustainable improvement in the overall health of members. Catamaran is headquartered in Lisle, Ill. with multiple locations in the U.S. and Canada. For more information, please visit www.catamaranRx.com.

SOURCE SXC Health Solutions Corp.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs